Cladanthus is a small genus of twelve species with an accepted name, which are all native of the Mediterranean region and southwestern Europe (www.worldfloraonline.org accessed on 9 November 2023). They are characteristic of the sunflower family. Five species are found in Morocco: Cladanthus mixtus (L.) Chevall, Cladanthus arabicus (L.) Cass, Cladanthus scariosus (Ball) Oberpr. and Vogt, Cladanthus eriolepis (Maire) Oberpr. and Vogt, and Cladanthus flahaultii (Emb). Oberpr. and Vogt. With feathery leaves and a daisy-like appearance with gold or white flowers, in general, these Mediterranean plants do not go unnoticed in fields and gardens. The prevalent species in Morocco are C. scariosus which is endemic in the High Atlas area ^[1][2][1,2] and the flavonoid-rich species C. mixtus in other areas [3]. The latter Cladanthus species is a prominent source of polyphenols and flavonoids, such as the glycosyl-flavone acetylisospinosin, which has recently been identified together with many other flavonoids ^[4][5][4,5].

C. arabicus (Figure 1) displays feathery leaves and a daisy-like appearance with gold flowers. It is commonly called Arabian Cladanthus or criss-cross, golden of Araby, golden crown, palm springs daisy, or Moroccan sunshine, as well as wild Moroccan chamomile although this later trivial name is more often associated with the species C. mixtus [6]. C. arabicus (L.) Cass. is the commonly used name and the accepted botanical name. There are several synonyms, such as C. maroccanus Gand. and Anthemis arabica L., but they are rarely used in the scientific literature.

As a perennial herb, C. arabicus represents an attractive flowering plant, native to the Ibero–Maghreb region (Algeria, Libya, Morocco, Sicily, Spain, and Tunisia). It is a hardy or half-hardy and annual and can self-seed in light, sandy soils. The plant, very branched and up to 80 cm high, grows well on ordinary, drained soil in full sun. It behaves as a bushy and spreading plant forming a colored mound of pleasantly scented feathery foliage. All summer, it provides a profusion of large, fragrant, golden-yellow flowers. The main flower on each stem is followed by further flowers on stems arising directly under the main one (Figure 1). The ferny foliage gives rise to many golden discs, and generally each new stem radiates from the edge of the faded flower. The plant is not considered edible but the flowers can be used to garnish dishes. In Morocco, the flowers (called Tâfs (or Tafsse) in the Arabic language, and Aourzid in the vernacular Amazigh language) are used by the Messiwa people to decorate dishes and are consumed ^[7][8][7,8]. The plant is eaten by wild herbivores, notably by Moroccan dorcas gazelle in west-central Morocco [9] and by camels but with a risk of toxicity in this later case [10].

2. Use of C. arabicus in Traditional Medicine

Ensuring a sustainable supply of affordable medicines for the world’s fast-growing population (which now surpass 8 billion people) is a major challenge in today’s economy. The challenges are even broader for people with low resources living in rural areas. There is a major need to improve access to and the affordability of health care in rural communities ^[11][12][11,12]. The World Health Organization (WHO) has estimated that about 80% of the world’s population use traditional medicine or rely on plant-based therapy for their primary care needs [13]. Plants have long been used as traditional remedies to help fight human diseases and remain largely used today to combat parasitic and virus infections, cardiovascular, mental, and inflammatory diseases, cancers, and many other pathologies ^[14][15][14,15]. Moreover, the demand for health-promoting products is increasing [16]. Plants still represent a large untapped source of structurally novel compounds that might serve as a lead in the development of novel drugs [17]. Many medicines of plant origin with analgesic and anti-nociceptive activity have been used for a long time without any major adverse effects ^[18][19][18,19]. Similarly, traditional herbal medicines and natural plant products contribute considerably to the treatment of cancers ^[20][21][20,21]. The bioprospection of medicinal plants remains a valid approach to identify new molecules which could be active against cancer and inflammatory diseases ^[22][23][24][22,23,24]. The use of C. arabicus in traditional medicine is not largely documented, with only sparse citations in scientific reviews. The plant is known in Morocco for the treatment of diabetes [25]. Apparently, an infusion prepared from the flower heads of the plant, drunk twice a day, could be useful to combat type 2 diabetes ^[26][27][26,27] (Figure 2). C. arabicus can be used alone or combined with other plants, such as Rubia peregrina, Corrigiola telephiifolia, or Ridolfia segetum, to prepare an antidiabetic decoction [28]. There are other reports primarily citing the use of the species C. mixtus (L.) Chevall [29] and C. scariosus (Ball) Oberpr. and Vogt [30], but not C. arabicus, for the treatment of diabetes. Other anti-diabetic Moroccan Asteraceae are cited also ^[31][32][31,32] and could be combined with C. arabicus. Beyond diabetes, the uses of C. arabicus for the treatment of digestive disorders, neurological troubles, and respiratory and urogenital affections have been mentioned, without much detail [33]. Apparently, the plant is “good for stomach and anemia” but robust experimental evidence to support these claims is lacking [7].

3. Pharmacological Activities of C. arabicus Extracts

Essential oils (EO) extracted from the aerial parts of C. arabicus have revealed the marked antimicrobial activities associated with a rich monoterpenic compounds content (Figure 2). In particular, an essential oil derived from the plant stems and leaves showed antibacterial activities against the opportunistic human pathogen Bacillus cereus and Enterococcus faecalis which is at the origin of nosocomial infections, but it showed no effect against the hard-to-treat pathogen Pseudomonas aeruginosa. This leaf/stem-derived EO principally contained the monoterpenes sabinene (13%), α-pinene (8%), β-pinene (12%), myrcene (7%), and many other volatile terpenes in smaller proportions (36 monoterpenes were identified) (Figure 3). An EO prepared under identical conditions from the plant’s flowers revealed a much poorer monoterpenes content, essentially only sabinene (23%) and β-pinene (32%) [34]. The composition of the essential oil can vary significantly from one study to another, depending on the process, the plant origin and its growth, or the collecting season. For example, an EO made from C. arabicus’ aerial parts was found to contain up to 60 terpenic compounds, principally sabinene (31%), β-pinene (17%), myrcene (12%) and α-pinene (5%). In this case, the EO was characterized for its strong antioxidant activity (IC₅₀ = 55.4 μg/mL in a DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging assay) and its antimicrobial effects, notably against Micrococcus luteus bacterium and the pathogenic fungus Candida albicans (MIC = 0.187 mg/mL in both cases) [35]. In a subsequent study, the same authors further tested this EO against other microbes and found activities against Escherichia coli (strain ATCC 25922), Klebsiella pneumoniae (strain S12b/16), and Enterobacter cloacae (strain S5/16), but at significantly higher doses than were measured for reference antibiotics such as amoxicillin and neomycin. Interestingly, the EO showed a synergistic activity with amoxicillin against Proteus mirabilis (strain S32/16), a Gram-negative bacterium that is frequently implicated in urinary tract infections [36]. The potent antibacterial activity of C. arabicus EO and its strong interaction with amoxicillin warrant further investigation. Apparently, the terpene content of C. arabicus EO is quite variable from one preparation to another. Recently, Mziouid and coworkers [37] reported the antioxidant activity of an EO from C. arabicus which contained α-pinene (5.7%) and β-pinene (23.6%), but also a large proportion of tau-cadinol (9.5%) (Figure 3), a sesquiterpene commonly found in EOs but not mentioned in the aforementioned preparations using C. arabicus. T-cadinol is known to be an anti-trypanosomal agent which is able to induce a mitochondrial impairment in Trypanosoma cruzi parasites responsible for the Chagas disease [38]. The C. arabicus EO also contained diethyl phthalate (DEP, 7.9%) which is an unwanted estrogenic endocrine-disrupting chemical (Figure 3). In this case, the EO exhibited a modest antioxidant activity (IC₅₀ = 1.33 mg/mL in the DPPH assay) [37]. A well-established, robust process is needed to prepare an EO in a reproducible manner with a constant, stable composition, which is free from toxic chemicals (following the recommendations of the European Pharmacopoeia, for example). The antioxidant activity is more pronounced when a total plant extract is used instead of an EO. For example, the antioxidant IC₅₀ value dropped from 1.33 mg/mL to 0.23 mg/mL when a methanolic extract was used in place of the EO from C. arabicus, due to the high phenolic content of the extract [37]. A phytochemical analysis of an alcoholic extract of the aerial parts of C. arabicus has revealed the presence of two major components, caffeic acid (4.9 mg/kg) and protocatechuic acid (4.7 mg/kg), followed with other polyphenols such as ferulic acid (1.8 mg/kg), 4-hydroxybenzoic acid (1.5 mg/kg), vanillin, and vanillic acid (both 1.6 mg/kg), plus a series of minor components including flavonoids which are sometimes glycosylated (diosmetin, luteolin, apigenin-7-glucoside) (Figure 3). The high polyphenols content, notably caffeic acid, suggests a possible use of the plant in combatting adverse hematologic events such as thrombocytopenia [39]. Caffeic acid is a strong antioxidant and an anti-inflammatory agent with cardioprotective and hepatoprotective effects. This common natural product is considered to be beneficial in limiting the progression of diabetes mellitus and its associated complications [40]. Protocatechuic acid is also a chemoprotective agent which is notably able to protect cardiomyocytes from oxidative damages [41]. These two polyphenols are commonly found in fruits, vegetables, grains, and herbal medicine; thus, they are definitely not specific to C. arabicus. Nevertheless, these compounds are important. Polyphenols from Mediterranean plants have benefits in the prevention and treatment of various diseases, notably skin diseases such as atopic dermatitis, psoriasis, and chronic urticaria [42]. In C. arabicus extracts, the polyphenol content was rich, whereas the levels of heavy metals (Cd, As and Pb) were low, and the extract revealed a marked antibacterial activity against Escherichia coli strain S33/16 (MIC = 0.125 mg/mL) [43]. The same hydro-methanolic extract has revealed the presence of diverse flavonoids and phenolic acids, including isochlorogenic acid and cinnamic acid (Figure 3). All together, these compounds are responsible for the marked antioxidant activity of the extract, as well as its modest inhibitory activity toward cholinesterase, acetylcholinesterase, tyrosinase, and α-glucosidase enzymes [44].

4. Phytochemical Analysis

The first phytochemical analysis of C. arabicus was reported 30 years ago, when Daniewski and coworkers reported the isolation of a new sesquiterpene they called cladantholide from a methanolic extract of the total dried aerial parts (without flowers) of a sample of C. arabicus cultivated locally [45]. The product is abundant in the plant. Over 100 mg of the newly purified product was obtained from an initial 1.46 kg of the dried plant material. Cladantholide corresponds to a three-ring system with a central seven-membered ring fused to planar a cyclo-pentenone ring on one side and a five-membered lactone ring on the other side (Figure 4). It is an isomer of cichoralexin (first isolated from chicory [Cichorium intybus] also known as Carpesia lactone [46]) and is a close analogue to the two sesquiterpene lactones leucodin and achillin (Figure 5) found in Achillea species. These two products display antihypertensive and vasorelaxant effects [47]. They also exhibit anti-inflammatory properties via the inhibition of cyclooxygenase 2 (COX-2) expression and activity. They are considered to be of potential interest in the treatment of pain and inflammation and for cardiometabolic diseases [48]. Leucodin has revealed a high anti-hypercholesterolemic potential [49,50] coupled with smooth muscle relaxant activity [47,51]. This type of 6,12-guaianolide structure (Figure 5) has been found in diverse Achillea species (Asteraceae) notably those used to prepare chamomile herbal tea [52].

                                                             Figure 4. Structures cladantholide and sintenin isolated from the stems and leaves of C. arabicus.

                                                            Figure 5. Structures of several guaianolides related to cladantholide and germacranolides related to sintenin.

Cladantholide has been isolated from C. arabicus together with the germacranolide derivative sintenin (Figure 4), which is also a sesquiterpenoid found in diverse Achillea species, such as A. clavennae, A. millefolium, and others [53,54]. Sintenin is a sesquiterpene lactone initially isolated from the aerial parts of Achillea sintenisii Hub.-Mor. (Compositae) [55] and is also present in A. falcata L. [56] and A. micrantha Willd. [57]. But the sintenin content in Achillea plants is limited. For example, only 6 mg of sintenin was obtained from 1.37 kg of the dried aerial parts of A. sintenisii [55]. A much higher quantity can be obtained from the stems and leaves of C. arabicus. Recently, cladantholide has also been identified from the plant species of Scorzonera longiana Sümbül (an endemic species to Turkey), together with other terpenes and dihydroisocoumarin derivatives [58]. The undergrounddry parts (rootstock, 600 g) of S. longiana afforded 10.7 mg of cladantholide, which is 4-times less than the yield obtained from the dried aerial parts of C. arabicus. This latter fast-growing and easily accessible plant can provide a convenient source of cladantholide.

Alternatively, the product can be obtained by chemical synthesis. The total synthesis of (+)-cladantholide was reported in 1997, starting from ()-carvone via a long and tedious procedure (16 steps, 5.0% overall yield) implicating a cis-fused hydroazulenic lactone intermediate, as depicted in Figure 6 [59]. This clever chemical work based on a radical cyclization cascade has been recognized as a remarkable synthesis of a complex guaianolide [60]. This is a technical tour-de-force and still the only stereoselective synthesis described thus far to obtain (+)-cladantholide (the (−)-isomer was not obtained). In recent years, several chemical procedures have been described to produce other 6,12-guaianolides [61], but none to specifically produce cladantholide apart from the original process described 27 years ago [59].

             Figure 6. Total synthesis of (+)-cladantholide, as originally reported [59] and summarized [60]. Details of the 16 steps can be found in the original reports.

Sintenin is even more abundant than cladantholide in C. arabicus [45]. A dried sample of the plant (1.46 kg) was used to obtain 105 mg of cladantholide and 120 mg of sintenin (Figure 4). Over the past 30 years, these two compounds have rarely been reported. Sintenin and its epoxide derivative micranthin have been identified in an ethyl acetate extract of the aerial parts of the plant Achillea biebersteinii Afan. and the extract was well characterized for its antidiabetic and gastric antisecretory effects [62]. It is therefore plausible that sintenin contributes to the antidiabetic effect of C. arabicus. Sintenin is a non-cytotoxic lactone, with no effect on the proliferation of different types of cancer cells [53,54]. Sesquiterpene lactones often present marked antitumor properties, such as those isolated from the Inula species for example [63,64], but it is not the case for sintenin and cladantholide, both non-cytotoxic compounds. They deserve further studies as anti-inflammatory and antidiabetic agents. Interestingly, a structural analogy can be seen between cladantholide and the sesquiterpene lactone geigerianoloide isolated from the antidiabetic plant Geigeria alata (DC) Oliv. and Hiern. (also from the Asteraceae family) [65] (Figure 5).

Parenthetically, caution must be exercised when studying the scientific literature because a totally distinct product exists which is also called sintenin, which is a naturally occurring ester, (3-(3,4-dimethoxyphenyl)propyl 3-(3,4-dimethoxyphenyl)propanoate) with cytotoxic properties, used as a template for the synthesis of derivatives endowed with antioxidative and neuroprotective activities [66,67]. This ester sintenin has nothing to see with lactone sintenin from C. arabicus which is a non-cytotoxic compound.

Beyond cladantholide and sintenin, two other sesquiterpenes designated (+)-I and (+)-II (Figure 5) have been isolated from the original methanolic extract of a sample of C. arabicus (cultivated in Poland). The corresponding structures were presented but no specific information was reported [68]. Compound I is unknown. Compound II is an analogue of sintenin lacking one of the two acetyl groups. We could not find these two compounds in chemical databanks.

Five other products should be mentioned at this stage, the alkaloids embellicines A and B, and three polyketides named embeurekols A–C (A and B are isomers) but they originate from an endophyte fungus Embellisia eureka (renamed Alternaria eureka) not directly from C. arabicus [69,70] (Figure 7). This fungus grows on the surface of healthy stem tissues of C. arabicus in Morocco. It can be cultivated and used for the biotransformation of natural products, performing oxygenation, oxidation, and epoxidation reactions on sapogenins for example [71–73]. Similarly, the small bicyclic molecule 3,4-dihydro-3,4,8-trihydroxy-1[2H]-naphthalenone (Figure 7) has been isolated from an extract of Embellisia eureka collected on a Moroccan sample of C. arabicus [74]. Trihydroxytetralones are bioactive secondary metabolites produced by diverse pathogenic fungi [75–77].

                                                Figure 7. Structures of several guaianolides related to cladantholide and germacranolides related to sintenin.

 Most phytochemical studies of C. arabicus are concerned with the terpenes and alkaloids found in the plant. But, as mentioned above, diverse flavonoids have been identified in plant extracts, such as apigenin and its glycosyl derivative apigenin-7-glucoside [36,44]. Another flavonoid of medicinal interest found in C. arabicus is diosmetin [43] (Figure 3). This common flavonoid, found in many plants, displays anti-inflammatory, antioxidant, antimicrobial, antilipolytic, and analgesic activities [78]. Diosmetin might well contribute to the antidiabetic action of C. arabicus extracts because it has been shown to ameliorate glucose metabolism in diabetic mice via the regulation of the PI3K/AKT signaling pathway and a restoration of the unbalanced gut microbiota [79]. It is an inhibitor of aldose reductase (IC₅₀ = 15.7 µM), an enzyme of the polyol pathway implicated in hyperglycemia, and a useful compound to combat type 2 diabetes mellitus [80,81].

References

[1] Bellioua, S.; Amari, S.; Warda, K.; Aghraz, A.; Dilagui, I.; Ouhaddou, S.; Sissi, S.; Bekkouche, K.; Larhsini, M.; Markouk, M. Chemical profile, antioxidant and antimicrobial effects of essential oil from the Moroccan endemic plant Cladanthus scariosus (L.). J. Essent. Oil Res. 2022, 34, 394–404.

[2] El Hafidi, S.; Bakhy, K.; Ouhssine, M.; Benzakour, A.; Khamar, H.; Casanova, J.; Paoli, M.; Tomi, F. Composition and Chemical Variability of the Essential Oil from Aerial Parts of Cladanthus scariosus, an Endemic Species to the Moroccan High Atlas. Chem. Biodivers. 2023, 20, e202201022.

[3] Elouaddari, A.; El Amrani, A.; JamalEddine, J. Intraspecific variability of the essential oil of Cladanthus mixtus from Morocco. Nat. Prod. Commun. 2014, 9, 133–136.

[4] Benmerache, A.; Alabdul Magid, A.; Kabouche, A.; Harakat, D.; Voutquenne-Nazabadioko, L.; Kabouche, Z. 6"'-O-acetylisospinosin, a new C-glycosylflavone and known compounds from the aerial parts of Cladanthus mixtus. Nat. Prod. Res. 2020, 34, 2887–2893.

[5] El Mihyaoui, A.; Erbiai, E.H.; Charfi, S.; Pinto, E.; Castillo, M.E.C.; Hernández-Ruiz, J.; Cano, A.; Badoc, A.; Lamarti, A.; Esteves da Silva, J.C.G.; et al. Chemical Characterization and Several Bioactivities of Cladanthus mixtus from Morocco. Molecules 2023, 28, 3196.

[6] Elouaddari, A.; El Amrani, A.; Eddine, J.; Correia, A.I.D.; Barroso, J.G.; Pedro, L.G.; Figueiredo, A.C. Yield and chemical composition of the essential oil of Moroccan chamomile [Cladanthus mixtus (L.) Chevall.] growing wild at different sites in Morocco. Flavour Fragance J. 2013, 28, 360–366.

[7] Ghanimi, R.; Ouhammou, A.; Babahmad, R.A.; Cherkaoui, M. A Quantitative Study on the Ethnobotanical Knowledge about Wild Edible Plants among the Population of Messiwa. Ethiop. J. Health Sci. 2022, 32, 1237–1244.

[8] Ghanimi, R.; Ouhammou, A.; Ahouach, A.; Cherkaoui, M. Ethnobotanical study on wild edible plants traditionally used by Messiwa people, Morocco. J. Ethnobiol. Ethnomed. 2022, 18, 16.

[9] Ait Baamrane, M.A.; Shehzad, W.; Ouhammou, A.; Abbad, A.; Naimi, M.; Coissac, E.; Taberlet, P.; Znari, M. Assessment of the food habits of the Moroccan dorcas gazelle in M'Sabih Talaa, west central Morocco, using the trnL approach. PLoS ONE 2012, 7, e35643.

[10] Blajan, L.; Lasnami, K. Nutrition et pathologie du dromadaire. Options Méditerr. 1989, 2, 131–139.

[11] Kumar, P.; Kumar, R. Rural Health Scenario—Role of family medicine: Academy of Family Physicians of India Position Paper. J. Fam. Med. Prim. Care 2018, 7, 1157–1162.

[12] Kolié, D.; Van De Pas, R.; Codjia, L.; Zurn, P. Increasing the availability of health workers in rural sub-Saharan Africa: A scoping review of rural pipeline programmes. Hum. Resour. Health 2023, 21, 20.

[13] WHO established the global center for traditional medicine in India. Available online: https://www.who.int/news/item/25-03-2022-who-establishes-the-global-centre-for-traditional-medicine-in-india (accessed on 9 November 2023).

[14] Šantić, Ž.; Pravdić, N.; Bevanda, M.; Galić, K. The historical use of medicinal plants in traditional and scientific medicine. Psychiatr. Danub. 2017, 29, 787–792.

[15] Cingi, C.; Bayar Muluk, N.; Tezol, A.; Çukurova, I. Efficacy of traditional herbal formulas on human immunity. Eur. Rev. Med. Pharmacol. Sci. 2023, 27, 27–40.

[16] Kurek, M.; Benaida-Debbache, N.; Elez Garofulić, I.; Galić, K.; Avallone, S.; Voilley, A.; Waché, Y. Antioxidants and Bioactive Compounds in Food: Critical Review of Issues and Prospects. Antioxidants 2022, 11, 742.

[17] Guo, K.; Liu, Y.; Li, S.H. The untapped potential of plant sesterterpenoids: Chemistry, biological activities and biosynthesis. Nat. Prod. Rep. 2021, 38, 2293–2314.

[18] Calixto, J.B.; Beirith, A.; Ferreira, J.; Santos, A.R.; Filho, V.C.; Yunes, R.A. Naturally occurring antinociceptive substances from plants. Phytother. Res. 2000, 14, 401–418.

[19] Dewanjee, S.; Sohel, M.; Hossain, M.S.; Ansari, F.; Islam, M.T.; Sultana, F.; Al Mamun, A.; Islam, M.M.; Amin, M.N. A comprehensive review on clinically proven natural products in the management of nerve pain, with mechanistic insights. Heliyon 2023, 9, e15346.

[20] Kooti, W.; Servatyari, K.; Behzadifar, M.; Asadi-Samani, M.; Sadeghi, F.; Nouri, B.; Zare Marzouni, H. Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study. J. Evid. Based Complement. Altern. Med. 2017, 22, 982–995.

[21] Aiello, P.; Sharghi, M.; Mansourkhani, S.M.; Ardekan, A.P.; Jouybari, L.; Daraei, N.; Peiro, K.; Mohamadian, S.; Rezaei, M.; Heidari, M.; et al. Medicinal Plants in the Prevention and Treatment of Colon Cancer. Oxid. Med. Cell Longev. 2019, 2019, 2075614.

[22] Menezes, R.; Foito, A.; Jardim, C.; Costa, I.; Garcia, G.; Rosado-Ramos, R.; Freitag, S.; Alexander, C.J.; Outeiro, T.F.; Stewart, D.; et al. Bioprospection of Natural Sources of Polyphenols with Therapeutic Potential for Redox-Related Diseases. Antioxidants 2020, 9, 789.

[23] Rosa, M.N.; E Silva, L.R.V.; Longato, G.B.; Evangelista, A.F.; Gomes, I.N.F.; Alves, A.L.V.; de Oliveira, B.G.; Pinto, F.E.; Romão, W.; de Rezende, A.R.; et al. Bioprospecting of Natural Compounds from Brazilian Cerrado Biome Plants in Human Cervical Cancer Cell Lines. Int. J. Mol. Sci. 2021, 22, 3383.

[24] Rani, D.M.; Wongso, H.; Purwoko, R.Y.; Winarto, N.B.; Shalas, A.F.; Triatmoko, B.; Pratama, A.N.W.; Keller, P.A.; Nugraha, A.S. Anti-cancer bioprospecting on medicinal plants from Indonesia: A review. Phytochemistry 2023, 216, 113881.

[25] Idm’hand, E.; Msanda, F.; Cherifi, K. Ethnopharmacological review of medicinal plants used to manage diabetes in Morocco. Clin. Phytosci. 2020, 6, 18.

[26] Benkhnigue, O.; Ben Akka, F.; Salhi, S.; Fadli, M.; Douira, A.; Zidane, L. Catalogue des plantes médicinales utilisées dans le traitement du diabète dans la région d’Al Haouz-Rhamna (Maroc). J. Anim. Plant Sci. 2014, 23, 3539–3568.

[27] Belhaj, S.; Chaachouay, N.; Zidane, L. Ethnobotanical and toxicology study of medicinal plants used for the treatment of diabetes in the High Atlas Central of Morocco. J. Pharm. Pharmacog. Res. 2021, 9, 619–662.

[28] Benkhnigue, O.; Chaachouay, N.; Khamar, H.; El Azzouzi, F.; Douira, A.; Zidane, L. Ethnobotanical and ethnopharmacological study of medicinal plants used in the treatment of anemia in the region of Haouz-Rehamna (Morocco). J. Pharm. Pharmacogn. Res. 2022, 10, 279–302.

[29] Ouhaddou, H.; Alaoui, A.; Laaribya, S.; Ayan, S. Ethnobotanical survey of medicinal plants used for treating diabetes in Agadir Ida Outanane region, Southwestern Morocco. Arab. J. Med. Aromat. Plants 2020, 6, 72–86.

[30] Katiri, A.; Karkaoui, M.; Msanda, F.; Boubaker, H. Ethnobotanical Survey of Medicinal Plants Used for the Treatment of Diabetes in the Tizi n’ Test Region (Taroudant Province, Morocco). J. Pharmacogn. Nat. Prod. 2017, 3, 1000130.

[31] Chaachouay, N.; Benkhnigue, O.; Fadli, M.; El Ibaoui, H.; Zidane, L. Ethnobotanical and ethnopharmacological studies of medicinal and aromatic plants used in the treatment of metabolic diseases in the Moroccan Rif. Heliyon 2019, 5, e02191.

[32] Naceiri Mrabti, H.; Bouyahya, A.; Naceiri Mrabti, N.; Jaradat, N.; Doudach, L.; Faouzi, M.E.A. Ethnobotanical Survey of Medicinal Plants Used by Traditional Healers to Treat Diabetes in the Taza Region of Morocco. eCAM 2021, 2021, 5515634.

[33] Daoudi, A.; Bammou, M.; Zarkani, S.; Slimani, I.; Ibijbijen, J.; Nassiri, L. Ethnobotanical study of medicinal flora in rural municipality of Aguelmouss—Khenifra province—(Morocco). Phytothérapie 2016, 14, 220–228.

[34] El Hanbali, F.; Mellouki, F.; Akssira, M.; El hassani, B.; Blázquez, M.A.; Boira, H. Composition and Antibacterial Activity of Essential Oils of Cladanthus arabicus Cass. (Asteraceae). J. Essent. Oil Bear. Plants 2005, 8, 213–217.

[35] Aghraz, A.; Wanner, J.; Schmidt, E.; Aitdra, L.; Aitsidibrahim, M.; Tabanca, N.; Ali, A.; Nafis, A.; Hassani, L.; Markouk, M.; et al. Chemical Composition, in vitro Antioxidant, Antimicrobial and Insecticidal Activities of Essential Oil from Cladanthus arabicus. J. Essent. Oil Bear. Plants 2017, 20, 601–609.

[36] Aghraz, A.; Benameur, Q.; Gervasi, T.; Ait Dra, L.; Ben-Mahdi, M.H.; Larhsini, M.; Markouk, M.; Cicero, N. Antibacterial activity of Cladanthus arabicus and Bubonium imbricatum essential oils alone and in combination with conventional antibiotics against Enterobacteriaceae isolates. Lett. Appl. Microbiol. 2018, 67, 175–182.

[37] Mziouid, A.; Chebli, B.; Berrabah, M.; Chebli, H.; Heimeur, N.; Bounimi, S.; Mayad, E.H. Phytochemical screening and antioxidant activity of four Moroccan aromatic plant methanolic extracts and essential oils. Arab. J. Med. Aromat. Plants 2022, 8, 117–132.

[38] Dos Santos, A.L.; Amaral, M.; Hasegawa, F.R.; Lago, J.H.G.; Tempone, A.G.; Sartorelli, P. (-)-T-Cadinol-a Sesquiterpene Isolated From Casearia sylvestris (Salicaceae)-Displayed In Vitro Activity and Causes Hyperpolarization of the Membrane Potential of Trypanosoma cruzi. Front. Pharmacol. 2021, 12, 734127. Corrigendum in Front. Pharmacol. 2022, 13, 865432.

[39] Yu, H.; Chen, R.; Zhou, Z.; Liu, R.; Wen, J. Efficacy and safety of caffeic acid tablets in the treatment of thrombocytopenia: A systematic review and meta-analysis. Medicine 2023, 102, 35353.

[40] Ganguly, R.; Singh, S.V.; Jaiswal, K.; Kumar, R.; Pandey, A.K. Modulatory effect of caffeic acid in alleviating diabetes and associated complications. World J. Diabetes 2023, 14, 62–75.

[41] Okpara, E.S.; Adedara, I.A.; Guo, X.; Klos, M.L.; Farombi, E.O.; Han, S. Molecular mechanisms associated with the chemoprotective role of protocatechuic acid and its potential benefits in the amelioration of doxorubicin-induced cardiotoxicity: A review. Toxicol. Rep. 2022, 9, 1713–1724.

[42] Di Salvo, E.; Gangemi, S.; Genovese, C.; Cicero, N.; Casciaro, M. Polyphenols from Mediterranean Plants: Biological Activities for Skin Photoprotection in Atopic Dermatitis, Psoriasis, and Chronic Urticaria. Plants 2023, 12, 3579.

[43] Aghraz, A.; Albergamo, A.; Benameur, Q.; Salvo, A.; Larhsini, M.; Markouk, M.; Gervasi, T.; Cicero, N. Polyphenols contents, heavy metals analysis and in vitro antibacterial activity of extracts from Cladanthus arabicus and Bubonium imbricatum of Mo-roccan Origin. Nat. Prod. Res. 2020, 34, 63–70.

[44] Aghraz, A.; Gonçalves, S.; Rodríguez-Solana, R.; Ait Dra, L.; Di Stefano, V.; Dugo, G.; Cicero, N.; Larhsini, M.; Markouk, M.; Romano, A. Antioxidant activity and enzymes inhibitory properties of several extracts from two Moroccan Asteraceae species. S. Afr. J. Bot. 2018, 118, 58–64.

[45] Daniewski, W.M.; Danikiewicz, W.; Gumulka, M.; Pankowska, E.; Krajewski, J.; Grabarczyk, H.; Wichlacz, M. Sesquiterpenes of Cladanthus arabicus. Phytochemistry 1993, 34, 1639–1641.

[46] Monde, K.; Oya, T.; Takasugi, M.; Shirata, A. A guaianolide phytoalexin, cichoralexin, from Cichorium intybus. Phytochemistry 1990, 29, 3449–3451.

[47] Arias-Durán, L.; Estrada-Soto, S.; Hernández-Morales, M.; Chávez-Silva, F.; Navarrete-Vázquez, G.; León-Rivera, I.; Pe-rea-Arango, I.; Villalobos-Molina, R.; Ibarra-Barajas, M. Tracheal relaxation through calcium channel blockade of Achillea millefolium hexanic extract and its main bioactive compounds. J. Ethnopharmacol. 2020, 253, 112643.

[48] Perri, F.; Frattaruolo, L.; Haworth, I.; Brindisi, M.; El-magboub, A.; Ferrario, A.; Gomer, C.; Aiello, F.; Adams, J.D. Naturally occurring sesquiterpene lactones and their semi-synthetic derivatives modulate PGE2 levels by decreasing COX2 activity and expression. Heliyon 2019, 5, e01366. Corrigendum in Heliyon 2019, 5, e01513.

[49] Khazneh, E.; Hřibová, P.; Hošek, J.; Suchý, P.; Kollár, P.; Pražanová, G.; Muselík, J.; Hanaková, Z.; Václavík, J.; Miłek, M.; et al. The Chemical Composition of Achillea wilhelmsii C. Koch and Its Desirable Effects on Hyperglycemia, Inflammatory Mediators and Hypercholesterolemia as Risk Factors for Cardiometabolic Disease. Molecules 2016, 21, 404.

[50] Shang, Y.; Li, X.F.; Jin, M.J.; Li, Y.; Wu, Y.L.; Jin, Q.; Zhang, Y.; Li, X.; Jiang, M.; Cui, B.W.; et al. Leucodin attenuates inflammatory response in macrophages and lipid accumulation in steatotic hepatocytes via P2x7 receptor pathway: A potential role in alcoholic liver disease. Biomed. Pharmacother. 2018, 107, 374–381.

[51] Arias-Durán, L.; Estrada-Soto, S.; Hernández-Morales, M.; Millán-Pacheco, C.; Navarrete-Vázquez, G.; Villalobos-Molina, R.; Ibarra-Barajas, M.; Almanza-Pérez, J.C. Antihypertensive and vasorelaxant effect of leucodin and achillin isolated from Achillea millefolium through calcium channel blockade and NO production: In vivo, functional ex vivo and in silico studies. J. Ethnopharmacol. 2021, 273, 113948.

[52] Tschiggerl, C.; Bucar, F. Guaianolides and volatile compounds in chamomile tea. Plant Foods Human Nutr. 2012, 67, 129–135.

[53] Csupor-Löffler, B.; Hajdú, Z.; Zupkó, I.; Réthy, B.; Falkay, G.; Forgo, P.; Hohmann, J. Antiproliferative effect of flavonoids and sesquiterpenoids from Achillea millefolium s.l. on cultured human tumour cell lines. Phytother. Res. 2009, 23, 672–676.

[54] Trifunović, S.; Isaković, A.M.; Isaković, A.; Vučković, I.; Mandić, B.; Novaković, M.; Vajs, V.; Milosavljević, S.; Trajković, V. Isolation, characterization, and in vitro cytotoxicity of new sesquiterpenoids from Achillea clavennae. Planta Med. 2014, 80, 297–305.

[55] Gören, N.; Oksüz, S.; Ulubelen, A. A sesquiterpene lactone, sintenin, from Achillea sintenisii. Phytochemistry 1988, 27, 2346–2347.

[56] Bruno, M.; Rosselli, S.; Raccuglia, R.A.; Maggio, A.; Senatore, F.; Arnold, N.A.; Griffin, C.A.; Herz, W. Terpenoids and Flavones from Achillea falcata (Asteraceae). Rev. Soc. Quim. México 2003, 47, 130–131.

[57] Hatam, N.A.R.; Yousif, N.J.; Porzel, A.; Seifert, K. Sesquiterpene lactones from Achillea micrantha. Phytochemistry 1992, 31, 2160–2162.

[58] Korkmaz, B.; Renda, G.; Erik, İ.; Kılıç, G.; Coşkunçelebi, K.; Yaylı, N. Two new dihydroisocoumarins and terpenoids from Scorzonera longiana Sümbül an endemic species to Turkey and their antimicrobial activity. Nat. Prod. Res. 2023, 37, 1185–1198.

[59] Lee, E.; Yoon, C.H.; Sung, Y.S.; Kim, Y.K.; Yun, M.; Kim, S. Total Synthesis of (+)-Cladantholide and (−)-Estafiatin:  5-Exo,7-Endo Radical Cyclization Strategy for the Construction of Guaianolide Skeleton. J. Am. Chem. Soc. 1997, 119, 8391–8392.

[60] Schall, A.; Reiser, O. Synthesis of Biologically Active Guaianolides with a trans-Annulated Lactone Moiety. Eur. J. Org. Chem. 2008, 14, 2353–2364.

[61] Fernandes, R.A.; Moharana, S.; Khatun, G.N. Recent advances in the syntheses of guaianolides. Org. Biomol. Chem. 2023, 21, 6652–6670.

[62] Abd-Alla, H.I.; Shalaby, N.M.; Hamed, M.A.; El-Rigal, N.S.; Al-Ghamdi, S.N.; Bouajila, J. Phytochemical composition, protective and therapeutic effect on gastric ulcer and α-amylase inhibitory activity of Achillea biebersteinii Afan. Arch. Pharmacal Res. 2016, 39, 10–20.

[63] Bailly, C.; Vergoten, G. Japonicone A and related dimeric sesquiterpene lactones: Molecular targets and mechanisms of anticancer activity. Inflamm. Res. 2022, 71, 267–276.

[64] Migheli, R.; Virdis, P.; Galleri, G.; Arru, C.; Lostia, G.; Coradduzza, D.; Muroni, M.R.; Pintore, G.; Podda, L.; Fozza, C.; et al. Antineoplastic Properties by Proapoptotic Mechanisms Induction of Inula viscosa and Its Sesquiterpene Lactones Tomentosin and Inuviscolide. Biomedicines 2022, 10, 2739.

[65] Fadul, E.; Nizamani, A.; Rasheed, S.; Adhikari, A.; Yousuf, S.; Parveen, S.; Gören, N.; Alhazmi, H.A.; Choudhary, M.I.; Khalid, A. Anti-glycating and anti-oxidant compounds from traditionally used anti-diabetic plant Geigeria alata (DC) Oliv. & Hiern. Nat. Prod. Res. 2020, 34, 2456–2464.

[66] Hu, L.H.; Zou, H.B.; Gong, J.X.; Li, H.B.; Yang, L.X.; Cheng, W.; Zhou, C.X.; Bai, H.; Guéritte, F.; Zhao, Y. Synthesis and biological evaluation of a natural ester sintenin and its synthetic analogues. J. Nat. Prod. 2005, 68, 342–348.

[67] Yang, L.X.; Zhang, L.J.; Huang, K.X.; Li, X.K.; Hu, L.H.; Wang, X.Y.; Stockigt, J.; Zhao, Y. Antioxidant and neuroprotective effects of synthesized sintenin derivatives. J. Enzym. Inhib. Med. Chem. 2009, 24, 425–431.

[68] Wichlacz, M.; Daniewski, W.M.; Danikiewicz, W.; Gumulka, M.; Drozdz, B.; Grabarczyk, H. Constituents of Cladanthus Arabicus. Pol. J. Chem. 1994, 68, 2147–2152.

[69] Ebrahim, W.; Aly, A.H.; Mándi, A.; Wray, V.; Essassi el, M.; Ouchbani, T.; Bouhfid, R.; Lin, W.; Proksch, P.; Kurtán, T.; Debbab, A. O-heterocyclic embeurekols from Embellisia eureka, an endophyte of Cladanthus arabicus. Chirality 2013, 25, 250–256.

[70] Ebrahim, W.; Aly, A.H.; Wray, V.; Mándi, A.; Teiten, M.H.; Gaascht, F.; Orlikova, B.; Kassack, M.U.; Lin, W.; Diederich, M.; et al. Embellicines A and B: Absolute configuration and NF-κB transcriptional inhibitory activity. J. Med. Chem. 2013, 56, 2991–2999.

[71] Özçınar, Ö.; Özgür, T.; Yusufoglu, H.; Kivçak, B.; Bedir, E. Biotransformation of Neoruscogenin by the Endophytic Fungus Alternaria eureka. J. Nat. Prod. 2018, 81, 1357–1367.

[72] Duman, S.; Ekiz, G.; Yılmaz, S.; Yusufoglu, H.; Ballar Kırmızıbayrak, P.; Bedir, E. Telomerase activators from 20(27)-octanor-cycloastragenol via biotransformation by the fungal endophytes. Bioorg. Chem. 2021, 109, 104708.

[73] Küçüksolak, M.; Üner, G.; Ballar Kırmızıbayrak, P.; Bedir, E. Neuroprotective metabolites via fungal biotransformation of a novel sapogenin, cyclocephagenol. Sci. Rep. 2022, 12, 18481.

[74] Ouchbani, T.; Janati Idriss, F.E.; Bouhfid, R.; Proksch, P.; Essassi, E.M. Neonectria Macrodidyma and Embellisia eureka, two novel producers of brefeldin A and 3,4-dihydro-3,4-8-trihydroxy’1[2H]-naphthalenone. J. Maroc. Chim. Hétérocycl. 2012, 11, 23–35.

[75] Gremaud, G.; Tabacchi, R. Relationship between the fungus Ceratocystis fimbriata coffea and the canker disease of the coffee tree. Phytochemistry 1996, 42, 1547–1549.

[76] Okole, B.N.; Schulz, F.A. Selection of Mycosphaerella fijiensis-resistant cell lines from micro-cross sections of banana and plantain. Plant Cell Rep. 1997, 16, 339–343.

[77] Ancheeva, E.; Daletos, G.; Proksch, P. Bioactive Secondary Metabolites from Endophytic Fungi. Curr. Med. Chem. 2020, 27, 1836–1854.

[78] Garg, M.; Chaudhary, S.K.; Goyal, A.; Sarup, P.; Kumari, S.; Garg, N.; Vaid, L.; Shiveena, B. Comprehensive review on therapeutic and phytochemical exploration of diosmetin: A promising moiety. Phytomed. Plus 2022, 2, 100179.

[79] Gong, X.; Xiong, L.; Caihong, B.; Zhang, B. Diosmetin ameliorate type 2 diabetic mellitus by up-regulating Corynebacterium glutamicum to regulate IRS/PI3K/AKT-mediated glucose metabolism disorder in KK-Ay mice. Phytomedicine 2021, 87, 153582.

[80] Angamuthu, H.; Ramachandrane, M. Investigations on the structural, vibrational, computational, and molecular docking studies on potential antidiabetic chemical agent Diosmetin. J. Mol. Recogn. 2020, 33, e2819.

[81] Comakli, V.; Adem, S.; Oztekin, A.; Demirdag, R. Screening inhibitory effects of selected flavonoids on human recombinant aldose reductase enzyme: In vitro and in silico study. Arch. Physiol. Biochem. 2022, 128, 1368–1374.